NitikaSharmaMD

PubMed

• 11 citations
  Survival Is Worse in Patients Completing Immunotherapy Prior to SBRT/SRS Compared to Those Receiving It Concurrently or After.
  Susan Woody, Aparna Hegde, Hyder Arastu, M Sean Peach, Nitika Sharma, Paul Walker, Andrew W Ju> ;Frontiers in Oncology. 2022 Jan 1
• 4 citations
  Peripheral blood interleukin 6, interleukin 10, and T lymphocyte levels are associated with checkpoint inhibitor induced pneumonitis: a case report.
  Abdul Rafeh Naqash, Mona A. Marie, Druid C Atwell, Mahvish Muzaffar, Nitika Sharma, Suneetha Amara, Darla K. Liles, Paul R. Walker, Li V. Yang> ;Acta Oncologica. 2021 May 3
• 198 citations
  Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade.
  Chipman Rg Stroud, Aparna Madhukeshwar Hegde, Cynthia R. Cherry, Abdul Rafeh Naqash, Nitika Sharma, Srikala Addepalli, Sulochana Devi Cherukuri, Teresa Parent, Jessica...> ;Journal of Oncology Pharmacy Practice. 2019 Apr 1
• 15 citations
  Suppressive effects of iron chelation in clear cell renal cell carcinoma and their dependency on VHL inactivation
  Christopher Greene, Nitika Sharma, Peter N. Fiorica, Emily Forrester, Gary J. Smith, Kenneth W. Gross, Eric C. Kauffman> ;Free Radical Biology & Medicine. 2019 Mar 1
• 14 citations
  Malignant pleural effusion and cancer of unknown primary site: a review of literature.
  Saed Awadallah, Mark R. Bowling, Nitika Sharma, Arjun Mohan> ;Annals of Translational Medicine. 2019 Feb 7
• 46 citations
  Transferrin receptor 1 upregulation in primary tumor and downregulation in benign kidney is associated with progression and mortality in renal cell carcinoma patients.
  Christopher Greene, Kristopher Attwood, Nitika Sharma, Kenneth W. Gross, Gary J. Smith, Bo Xu, Eric C. Kauffman> ;Oncotarget. 2017 Nov 6
• 1 citations
  Metastatic melanoma in a 95 years old patient responding to treatment with talimogene laherparepvec followed by nivolumab
  Abdul Rafeh Naqash, Geoffrey Stroud, Frances A. Collichio, Mahvish Muzaffar, Nitika Sharma, Paul R. Walker> ;Acta Oncologica. 2017 May 8
• Join now to see all

Journal Articles

• Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade  
  Chipman RG Stroud, Aparna Hegde, Cynthia Cherry, Abdul R Naqash, Nitika Sharma, Srikala Addepalli, Sulochana Cherukuri, Teresa Parent, Jessica Hardin and Paul Walker, Journal Of Oncology Pharmacy Practice, 12/2017
• The Use of Liquid Biopsies in Patients With NSCLC  
  Bhadra, Krish MD; Garwood, Susan MD; Sharma, Nitika MD; Walker, Paul MD, Oncology Times, 11/2017
• Metastatic melanoma in a 95 years old patient responding to treatment with talimogene laherparepvec followed by nivolumab  
  Abdul R. Naqash , Geoffrey Stroud, Frances A. Collichio Division of Hematology/Oncology, Lineberger Comprehensive Center, University of North Carolina, NC, USA , Mahvi..., Acta Oncologica, 5/2017

Abstracts/Posters

• Systemic inflammatory response syndrome (SIRS) with immune checkpoint inhibitors.
  Nitika Sharma, Chipman Robert Geoffrey Stroud, Paul R. Walker, Cynthia R. Cherry, Sulochana Devi Cherukuri, Srikala Addepalli, Teresa Parent, Jessica Hardin, JCO, 5/2016
• Immune pneumonitis-related treatment discontinuations and outcomes in metastatic non-small cell lung cancer treated with nivolumab: A pooled analysis from a multi-inst...
  Abdul Rafeh Naqash, Dwight Hall Owen, Biagio Ricciuti, Yukihiro Toi, Rita Chiari, Nitika Sharma, Sandip H. Patel, Shunichi Sugawara, Cynthia R. Cherry, Jarred Thomas B..., J Clin Oncol, 2/2019
• Veristrat based stratification of responses to immune checkpoint blockade (ICB).
  Paul Walker, Nitika Sharma, CRG Stroud, Journal of Clinical Oncology, 5/2017
• Immune related adverse events (irAEs): A unique profile based on tumor type.
  Nitika Sharma, Prashanti Atluri, Chipman Robert Geoffrey Stroud, Paul R. Walker, Sulochana Devi Cherukuri, Cynthia R. Cherry, ..., Journal of Clinical Oncology, 5/2017
• Efficacy of PD-1 inhibitors in patients with metastatic non-small cell lung cancer (NSCLC) with KRAS or EGFR T790M mutations.
  Nitika Sharma, Chipman Robert Geoffrey Stroud, Paul R. Walker, Sulochana Devi Cherukuri, Mahvish Muzaffar, Cynthia R. Cherry, Teresa Parent, Jessica Hardin;, J Clin Oncol, 5/2017
• Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade
  Chipman Robert Geoffrey Stroud, Cynthia R. Cherry, Abdul Rafeh Naqash, Nitika Sharma, Sulochana Devi Cherukuri, Teresa Parent, Jessica Hardin, Paul R. Walker;, J Clin Oncol, 5/2017
• Evaluating the utility of pretreatment C-reactive protein (CRP) in survival stratification of advanced non-small cell lung cancer (NSCLC) treated with immune checkpoin...
  Abdul Rafeh Naqash, Chipman Robert Geoffrey Stroud, Cynthia R. Cherry, Nitika Sharma, Mohammed Umer Butt, Mahvish Muzaffar, Li V. Yang, Paul R. Walker, J Clin Oncol, 5/2018
• Post- progression treatment patterns in advanced lung cancer patients treated with nivolumab.
  Aparna Madhukeshwar Hegde, Cynthia R. Cherry, Chipman Robert Geoffrey Stroud, Nitika Sharma, Sulochana Devi Cherukuri, Mark Bowling, Andrew Wenhua Ju, Hyder Husain Ara..., J Clin Oncol, 5/2018
• Outcomes of immunomodulatory radiation strategies in combination with nivolumab compared with single agent nivolumab in lung cancer patients.
  Aparna Madhukeshwar Hegde, Cynthia R. Cherry, Chipman Robert Geoffrey Stroud, Ramya Pinnamaneni, Sulochana Devi Cherukuri, Nitika Sharma, Mark Bowling, Andrew Wenhua J..., J Clin Oncol, 5/2018
• Antibiotic use and overall survival in lung cancer patients receiving nivolumab.
  Tien Phuc Do, Aparna Madhukeshwar Hegde, Cynthia R. Cherry, Chipman Robert Geoffrey Stroud, Nitika Sharma, Sulochana Devi Cherukuri, Mark Bowling, Paul R. Walker, J Clin Oncol, 5/2018
• Modified Glasgow prognostic score in a North American population of metastatic lung cancer patients: Baseline characteristics from the SNAP trial.
  Chipman Robert Geoffrey Stroud, Paul R. Walker, Sulochana Devi Cherukuri, Nitika Sharma, Cindy Cherry, Teresa Parent, Jessica Hardin;, J Clin Oncol, 5/2017
• Outcomes with immune checkpoint inhibitor use in lung cancer patients with hepatic metastases.
  Srikala Addepalli, Chipman Robert Geoffrey Stroud, Sulochana Devi Cherukuri, Cynthia R. Cherry, Nitika Sharma, Teresa Parent, Jessica Hardin, Paul R. Walker;, J Clin Oncol, 2/2017
• PS01.36: Blood-Based Mutation Testing in Non–Small Cell Lung Carcinoma Patients Supports Individualized and Optimal Treatment
  Paul R. Walker, Mark Bowling, Sulochana Cherukuri, Nitika Sharma, Geoff Stroud, Cindy Cherry, Jessica Hardin, Teresa Parent, Journal of Thoracic Oncology, 11/2016
• Dark side of colchicine
  Nitika Sharma, Bhagyashri Navalkele, Charles Nnewihe, ACP NJ, 2013, 3/2013
• Join now to see all

Lectures

• Demographic stratification of inflammatory signature in lung cancer patients in North Carolina: A prospective cohort study. 
  2019 ASCO Annual Meeting - 6/1/2019
• Advances in Immune Therapy of Lung Cancer 
  11/2018
• ASCO update on Thoracic Cancers 
  9/2018
• Thoracic Molecular Tumor Board 
  Eastern North carolina Lung Cancer Symposium - 11/2017
• ASCO Molecular Tumor Board 
  Eastern AHEC - 9/2017
• Join now to see all